Imperial Recognized as 2025 Best & Brightest Company to Work For in West Michigan! Learn More

Imperial Clinical Research Services Blog
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
  • Services
    • What We Do
    • Study and Site Print Materials
    • Clinical Trial Translation Management
    • Ancillary Trial Supplies and Equipment
    • Clinical Trial Patient Engagement
    • CRO-Centered Services
    • A La Carte Services
  • Resources
    • Ebooks
    • Case Studies & Fact Sheets
  • About
    • About Us
    • News
    • Events
    • Corporate Responsibility
  • Contact
    • Contact Imperial
    • Career Opportunities
  • Blog
  • Marketplace
Author

Dan McDonald

Dan McDonald

Dan is vice president, business development, Imperial Clinical Research Services. Dan is a seasoned executive who specializes in identifying income opportunities, building strategic partnerships, and managing contract negotiations. A prolific and popular thought leader, Dan has presented at numerous industry conferences and events, has conducted workshops and sessions on patient engagement, and has been published numerous times in industry books, trade magazines, and journals.

    Business Insights

    Sustainability in Action: ESG and Clinical Research

    by Dan McDonald March 16, 2026
    written by Dan McDonald

    Sustainability has become a top priority for businesses and now shapes how they are evaluated and trusted. Companies in every industry are judged not only on their results and profits, but also on how they operate. In life sciences, using sustainable practices in clinical trials is an important factor when sponsors and CROs pick their partners and service providers. ESG, which stands for Environmental, Social, and Governance, provides organizations with a framework for measuring these efforts and setting clear standards for accountability.

    ESG in Clinical Research Is Now an Expectation, Not an Option

    Sustainability has become a strategic necessity that belongs at the center of every organization’s operations and long-term planning, driven by both ethical responsibility and financial performance. Today’s workforce increasingly seeks purpose-driven employers that demonstrate genuine environmental commitment, with a strong majority of job seekers viewing sustainable companies as more attractive places to work.

    Consumers are also aligning their spending habits with values, showing a clear willingness to support and even pay more for environmentally responsible brands. At the same time, global governments, investors, employees, and customers are calling for greater corporate accountability, particularly in addressing climate change.

    While ESG may be another acronym in an industry full of them, it carries real weight. It influences investor confidence, talent attraction and retention, supplier selection, and long-term success. Increasingly, it also shapes how sponsors and CROs evaluate their partners.

    What ESG Encompasses

    ESG standards evaluate companies across three core pillars:

    Environmental – Impact on the Planet

    • Greenhouse gas emissions and pollution control
    • Energy usage and efficiency
    • Waste reduction and recycling
    • Sustainable sourcing practices
    • Environmental policies and measurable goals

    Social – Impact on People

    • Diversity, equity, and inclusion initiatives
    • Employee health and safety
    • Human rights protections
    • Fair labor practices and wages
    • Community engagement and charitable efforts

    Governance – How a Company Operates

    • Ethical business conduct
    • Leadership accountability
    • Executive oversight and transparency
    • Risk mitigation practices
    • Compliance frameworks

    By prioritizing ESG criteria, companies can mitigate risks, attract top talent, and ensure long-term profitability. In clinical research, sponsors and CROs are now incorporating ESG factors into vendor qualification, RFPs, and capability assessments. Even when sustainability isn’t the primary focus, teams often integrate it into operational due diligence.

    Putting ESG to the Test

    Imperial takes its role as a corporate citizen seriously and has long maintained policies and procedures aligned with these principles. In recent years, we have worked intentionally to formalize, document, and strengthen them, ensuring they are measurable, transparent, and aligned with the expectations of the global sponsors and CROs we support.

    To benchmark our efforts, Imperial again participated in an independent evaluation through EcoVadis, a Paris-based global sustainability ratings provider widely recognized for its rigorous methodology.

    EcoVadis Bronze Medal Recognition for 2026

    We are proud to share that Imperial has been awarded the EcoVadis Bronze Medal for 2026.

    This recognition places Imperial among the top 35% of companies evaluated globally by EcoVadis in our category. It reflects measurable progress across key sustainability performance indicators. The rating also shows that Imperial’s performance aligns with top-tier sustainability practices worldwide.

    The EcoVadis assessment evaluates 21 sustainability criteria across core themes:

    • Environment: Reducing energy consumption, demonstrating water stewardship, and implementing environmental policies
    • Labor & Human Rights: Employee health and safety, diversity and inclusion benchmarks, fair labor practices, and human rights due diligence processes
    • Ethics: Anti-corruption training, data protection practices, whistleblower mechanisms, and formal compliance policies
    • Sustainable Procurement: Supplier ESG screening rates, adopting a supplier code of conduct, supply chain risk assessments, and responsible sourcing documentation

    The assessment process is comprehensive and includes extensive documentation review, policy validation, and evidence-based scoring. It also provides invaluable insights in the form of a detailed roadmap for continuous improvement, identifying areas where stronger data tracking, formalized policies, or expanded supplier engagement can enhance performance in the coming year.

    Why Independent Benchmarking of ESG Matters in Clinical Research

    Sustainability claims without verification carry little weight. Independent benchmarking provides credibility, accountability, and comparability.

    EcoVadis also functions as a secure information-sharing platform. For example, clients and prospective partners can access Imperial’s scorecard directly, reducing RFIs and increasing transparency.

    In life sciences, especially, ESG performance increasingly influences supplier selection. Large pharmaceutical companies and global CROs expect measurable sustainability commitments from their partners.

    ESG in Action at Imperial

    Sometimes, sustainability shows up in small but meaningful decisions. At industry conferences, for example, we evaluated the traditional promotional giveaways — often single-use plastic items — and chose a more responsible alternative.

    Instead of disposable gadgets, we distribute “second life” giveaways, such as plantable seed pencils and bamboo eco-friendly planter kits. The response has been overwhelmingly positive. More importantly, it aligns our brand presence with our values.

    Imperial is committed to enhancing our environmental stewardship, social responsibility, and governance practices while continuing to refine our processes to achieve measurable improvements. Working together, we can make a truly lasting impact.

    Resources

    • EcoVadis https://ecovadis.com/
    • Sustainability in Business: What It Is and Why It Matters https://www.seattleu.edu/business/online/albers/blog/what-is-sustainability-in-business
    • The Sustainability Puzzle: What Do Consumers Really Want? https://www.bain.com/insights/what-do-consumers-really-want-ceo-sustainability-guide-2024/
    • What is ESG and why does it matter for businesses? https://fsc.org/en/blog/what-is-esg
    • What is sustainability in business? https://www.ibm.com/think/topics/business-sustainability
    Sign Up For Imperial Blog Alerts
    Contact Us
    March 16, 2026 0 comment
    0 FacebookTwitterLinkedinEmail
  • Ancillary Trial Supplies and EquipmentBusiness InsightsLife-Science Events

    From Operations to Strategy: What SCOPE 2026 Revealed About the Future of Clinical Supply and RTSM

    by Dan McDonald February 5, 2026
    by Dan McDonald February 5, 2026

    The center of gravity in clinical trials is shifting. Conversations that once lived in separate silos, such as vendor onboarding, randomization, and trial supply management (RTSM), are now deeply interconnected. That reality was on full display while chairing the IRT/RTSM: Navigating the Digital Neighborhood component of…

    0 FacebookTwitterLinkedinEmail
  • Ancillary Trial Supplies and EquipmentBusiness InsightsSite Materials & Logistics

    Impact of Tariffs on Clinical Trials: Navigating Today’s New Reality

    by Dan McDonald January 8, 2026
    by Dan McDonald January 8, 2026

    Tariffs have always been part of clinical trials. Whenever supplies, equipment, or study materials cross borders, duties and fees are part of the process. For years, these costs were predictable enough to be absorbed into budgets and timelines. Sponsors and CROs planned accordingly, and study…

    0 FacebookTwitterLinkedinEmail
  • Ancillary Trial Supplies and EquipmentSite Materials & Logistics

    What Are The Essential Strategies for Study Supply and Equipment Planning?

    by Dan McDonald July 29, 2025
    by Dan McDonald July 29, 2025

    Clinical trials are dynamic endeavors, filled with numerous intricate components that must work together seamlessly for success. One of the most complex aspects of this process is study supply and equipment planning, which encompasses the procurement, storage, warehousing, and global distribution of ancillary equipment and…

    0 FacebookTwitterLinkedinEmail
  • Ancillary Trial Supplies and EquipmentLife-Science EventsSite Materials & Logistics

    Keeping Clinical Trials on Track: Navigating Supply Chains, Tariffs, and Regulatory Shifts

    by Dan McDonald April 10, 2025
    by Dan McDonald April 10, 2025

    Changes taking place in the United States and internationally may affect the clinical trials landscape in the months and even years to come. Here are a few observations: FDA The U.S. Department of Health and Human Services is reducing its workforce and streamlining its functions.…

    1 FacebookTwitterLinkedinEmail
  • Ancillary Trial Supplies and EquipmentBusiness InsightsClinical Trial Writing and DesignSite Materials & LogisticsTranslation of Study Materials

    How Can You Boost Clinical Trial Management Efficiency When Working with Vendors?

    by Dan McDonald February 26, 2025
    by Dan McDonald February 26, 2025

    Discover how to boost clinical trial management efficiency and minimize pain points for your next clinical study. The Complex Landscape of Clinical Studies The management hours required to oversee the many components of a clinical trial are substantial. Clinical operations teams typically concentrate on several…

    0 FacebookTwitterLinkedinEmail
  • Business InsightsPatient Recruitment and Retention

    On-Time Study Startup Challenges Are Lurking Around Every Corner: Don’t Panic! See Our Practical Solutions

    by Dan McDonald October 24, 2024
    by Dan McDonald October 24, 2024

    It’s Halloween, let’s cue the scary music! You know the theme, the single note on the high end of the piano played repeatedly. Yeah, that one. Being a sponsor of a global clinical trial is not for the weak-hearted! What makes a sponsor’s hair stand…

    1 FacebookTwitterLinkedinEmail
  • Ancillary Trial Supplies and EquipmentSite Materials & Logistics

    The Clinical Trial Ancillary Supplies and Equipment Universe: Making it Work

    by Dan McDonald June 26, 2024
    by Dan McDonald June 26, 2024

    The clinical trial ancillary supplies and equipment universe is a big one and it’s growing. Are you getting the right supplies to your global sites on time? Read on for more information. The vast universe of ancillary equipment and supplies is made up of a…

    2 FacebookTwitterLinkedinEmail
  • Ancillary Trial Supplies and EquipmentBusiness InsightsSite Materials & Logistics

    Medical Equipment for Clinical Trials: Rent vs. Buy – How Do You Decide?

    by Dan McDonald May 21, 2024
    by Dan McDonald May 21, 2024

    Finding the right protocol-compliant medical equipment for clinical trials is an important step in making sure the trial can be conducted successfully. Sponsors and CROs must also weigh the options of renting or purchasing. This blog guides you through the advantages and disadvantages of each…

    2 FacebookTwitterLinkedinEmail
  • Patient EngagementStudy Site Management

    Initiatives to Aid the Clinical Trials Industry: A Talk With Norman Goldfarb

    by Dan McDonald March 13, 2024
    by Dan McDonald March 13, 2024

    I recently caught up with my longtime friend and colleague, Norman Goldfarb. Norm is well-known to all of us in the clinical trials industry as an innovator and a best-practice thought leader for fostering clinical trial site relationships with sponsors and CROs. Norm’s resume is…

    0 FacebookTwitterLinkedinEmail
  • 1
  • 2
  • 3
  • …
  • 6

Welcome

Welcome

The Imperial blog features content of interest to life-science professionals, with a special focus on clinical trials. We hope you will enjoy our experts’ perspectives, and invite you to join the conversation by leaving your comments. Please let us know of any additional topics you would like to see covered here.

Signup for our Blog Subscription

Signup for our Blog Subscription

Keep in touch

Twitter Linkedin Youtube Email RSS

Popular Posts

  • 1

    Clinical Research Phases and the Path to Drug Approval

    August 8, 2023
  • 2

    See Do Get

    August 12, 2014
  • 3

    Google Translate: The Unwitting Confidentiality Flaw

    April 15, 2020
  • 4

    25 Reasons People Aren’t Enrolling in Your Clinical Trial

    October 29, 2015
  • 5

    Clinical Trial Supply Chains: The Key to Avoiding Disruptions

    May 10, 2022

Categories

  • Ancillary Trial Supplies and Equipment (34)
  • Business Insights (132)
  • Clinical Trial Writing and Design (39)
  • Life-Science Events (56)
  • Patient Engagement (38)
  • Patient Recruitment and Retention (98)
  • Site Materials & Logistics (50)
  • Study Site Management (22)
  • Translation of Study Materials (18)
Imperial Clinical Research Services Blog

Imperial is a global leader in clinical trial solutions and support, specializing in study and site print materials, ancillary trial supplies and equipment, clinical trial translation management, and clinical trial patient engagement.

Imperial CRS Corporate Headquarters
3100 Walkent Drive NW
Grand Rapids, MI 49544

Contact

connect@imperialcrs.com

800.777.2591

020 3887 3437

Employment

Social

We Run on EOS - Entrepreneurial Operating SystemEcovadis Sustainability Rating January 2024West Michigan's Best and Brightest Companies to Work For Winner 2025The Best and Brightest Companies to Work For Logo
© Imperial CRS, LLC | Privacy Policy
Signup for our Blog Subscription

Subscribe to our blog and get the latest updates, insights, and industry trends delivered straight to your inbox. Stay informed and never miss a post.